Brief: Austar Lifesciences Reports HY Revenue RMB1.10 Billion
29/08/2022 12:37
Aug 29 (Reuters) - Austar Lifesciences Ltd 6118.HK :
* HY REVENUE RMB1.10 BILLION VERSUS RMB855.4 MILLION
* HY PROFIT ATTRIBUTABLE RMB45.8 MILLION VERSUS RMB 217.9
MILLION
Further company coverage: 6118.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director